芬太尼復(fù)合氟比洛芬酯對(duì)乳腺癌根治術(shù)患者術(shù)后疼痛的影響
[Abstract]:Objective: to investigate the effect of intraoperative intravenous fentanyl combined with flurbiprofen ester on postoperative pain in patients with breast cancer. Methods: 60 patients undergoing radical mastectomy were randomly divided into three groups: fentanyl group (group F), fentanyl combined with flurbiprofen group (group KF) and control group (group N). All patients were anesthetized by endotracheal intubation. On the basis of routine anesthesia, the patients in group F were given flurbiprofen 1 mg / kg before skin incision and immediately after operation by intravenous 45min injection of fentanyl 2.0 渭 g / kg 路kg ~ (-1) after skin incision, and the patients in group N received intravenous fentanyl 2.0 渭 g 路kg ~ (-1) / kg of fentanyl intravenously after incision, and no special treatment was given to the patients in the group of Fentanyl 2.0 渭 g / kg of fentanyl. Pain visual analogue score (VAS) was used to evaluate the degree of pain in patients with postoperative pain after extubation for 6 h or 12 h, day 1, day 2, day 3, day 7, and to observe the use of other analgesics within 48 hours after operation and postoperative nausea and vomiting. Incidence of related adverse reactions such as respiratory suppression. Results: there was no significant difference in age, height, weight and clinicopathological features among the three groups (P0.05). The VAS scores of the patients in KF group were lower than those in group F and group N (P0.05). The VAS score of group F was lower than that of group N immediately after extubation (P0.05), but there was no significant difference in VAS score between group F and group N on day 1, day 2, day 1, day 2 (P0.05), VAS score of group 3 and day 7 after operation was higher than that of group N (P0.05). The difference was not statistically significant (P0.05); there was no significant difference between the three groups in the dosage of analgesics and the incidence of adverse reactions 48 hours after operation (P0.05). Conclusion: intraoperative intravenous injection of fentanyl combined with flurbiprofen ester can relieve early postoperative pain in patients with breast cancer, and does not increase the incidence of adverse reactions.
【學(xué)位授予單位】:廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類號(hào)】:R614
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳華軍;拾翠翠;周靜;;氟比洛芬酯超前鎮(zhèn)痛對(duì)圍術(shù)期應(yīng)激反應(yīng)及術(shù)后鎮(zhèn)痛效果的影響[J];重慶醫(yī)學(xué);2010年20期
2 許學(xué)兵;宋文濤;;小劑量右美托咪定復(fù)合曲馬多用于改良乳腺癌根治術(shù)后病人自控靜脈鎮(zhèn)痛的臨床效果[J];廣東醫(yī)學(xué);2012年17期
3 王琰;;氟比洛芬酯復(fù)合舒芬太尼用于全身麻醉術(shù)后鎮(zhèn)痛[J];臨床醫(yī)學(xué);2013年01期
4 佘守章;許學(xué)兵;;超前鎮(zhèn)痛有效性爭(zhēng)議及預(yù)防性鎮(zhèn)痛的研究新進(jìn)展[J];臨床麻醉學(xué)雜志;2008年06期
5 陳雄剛;陳百紅;林財(cái)珠;;氟比洛芬酯在大鼠手術(shù)切口組織中靶向分布的研究[J];臨床麻醉學(xué)雜志;2009年05期
6 徐建國(guó);;成人術(shù)后疼痛治療進(jìn)展[J];臨床麻醉學(xué)雜志;2011年03期
7 王曉山;劉沛;王東信;李世忠;丁婷;賈茜茜;;氟比洛芬酯復(fù)合舒芬太尼鎮(zhèn)痛對(duì)骨科患者術(shù)后譫妄發(fā)生率的影響[J];臨床麻醉學(xué)雜志;2012年02期
8 高玉潔;;非甾體抗炎藥物的臨床應(yīng)用及安全性評(píng)價(jià)[J];實(shí)用藥物與臨床;2009年02期
9 王小慧;王俊;;阿片類藥物誘導(dǎo)痛覺過敏的研究進(jìn)展[J];實(shí)用藥物與臨床;2011年05期
10 萬梅方;辜曉嵐;魯振;顧連兵;;不同時(shí)間點(diǎn)應(yīng)用氟比洛芬酯對(duì)食管癌患者術(shù)后靜脈自控鎮(zhèn)痛效果的影響[J];中華實(shí)用診斷與治療雜志;2013年02期
,本文編號(hào):2154602
本文鏈接:http://sikaile.net/yixuelunwen/mazuiyixuelunwen/2154602.html